LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine (pages 596–602)CN Sang, NM Ramadan, RG Wallihan, AS Chappell, FG Freitag, TR Smith, SD Silberstein, KW Johnson, LA Phebus, D Bleakman, PL Ornstein, B Arnold, SJ Tepper and F Vandenhende
Article first published online: 6 APR 2004 | DOI: 10.1111/j.1468-2982.2004.00723.x